Future Trends in FDA SaMD Policy and What They Mean for AI Driven Software The convergence of artificial intelligence (AI) and software as a medical device (SaMD) has ushered in a new era for digital health solutions. As regulatory expectations evolve, understanding the FDA SaMD framework becomes essential for professionals in the field. This article outlines the future trends in FDA SaMD policy and their implications for AI-driven software. Understanding FDA SaMD Framework The FDA’s Software as a Medical Device (SaMD) framework is pivotal in regulating software that performs medical functions without being part of a hardware medical device. This…

Preparing Briefing Packages for FDA Q Submissions on Novel SaMD Concepts The regulatory landscape surrounding Software as a Medical Device (SaMD) is ever-evolving. Utilizing a structured approach in preparing briefing packages for FDA Q submissions is critical for a successful engagement with the U.S. Food and Drug Administration (FDA). This tutorial provides a comprehensive, step-by-step guide tailored for digital health, regulatory, clinical, and quality leaders involved in the development and submission of SaMD products. By leveraging the FDA SaMD framework and adhering to applicable regulations, stakeholders can enhance their understanding of the nuances involved in the submission process. Understanding the…

Common Mistakes Digital Health Startups Make When Interpreting SaMD Rules The introduction of software as a medical device (SaMD) has markedly transformed the healthcare landscape. Digital health startups increasingly develop applications and AI solutions that provide diagnostic and therapeutic functions previously available only through traditional medical devices. However, implementing an effective FDA SaMD framework can be challenging, particularly for new entrants to the market. This article aims to identify and elaborate on common mistakes made by digital health startups when interpreting SaMD regulations, ultimately aiding in the development and commercialization of compliant digital health solutions. Understanding the Regulatory Landscape for…

Establishing Governance and RACI for SaMD Regulatory Ownership in Digital Health Firms In the evolving landscape of digital health, the governance framework for Software as a Medical Device (SaMD) has become paramount. This tutorial aims to delineate the necessary steps for establishing clear governance and a RACI (Responsible, Accountable, Consulted, and Informed) matrix specific to SaMD regulatory ownership. Understanding the components of the FDA SaMD framework and aligning them with a comprehensive regulatory strategy is crucial for ensuring compliance and fostering innovation. Understanding the FDA SaMD Framework The FDA defines SaMD as software intended to be used for medical purposes…

Total product lifecycle TPLC approach for SaMD oversight by FDA Total Product Lifecycle (TPLC) Approach for SaMD Oversight by FDA The evolving landscape of digital health technologies has prompted regulatory bodies, particularly the FDA, to refine their frameworks for Software as a Medical Device (SaMD). The FDA SaMD framework is critical for ensuring that developers and manufacturers adhere to the appropriate regulations throughout the product lifecycle. This article provides a comprehensive, step-by-step tutorial on implementing the Total Product Lifecycle (TPLC) approach for SaMD oversight, aligned with FDA expectations and regulations. Understanding the FDA SaMD Framework The FDA defines software as…